Atlas Trials

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Clinical trial NCT03580408 · COMPLETED

Trial details

NCT number
NCT03580408
Sponsor
The Lymphoma Academic Research Organisation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin LymphomaCoexisting Medical Conditions
Start date
2018-08-31
Primary completion
2021-02-19
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.